Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/02/2012
PIL CRIXIVAN 200 mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 28/07/2011 and displayed until 21/02/2012
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
Updated on 23/06/2010 and displayed until 28/07/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 25/01/2010 and displayed until 23/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 20/11/2008 and displayed until 25/01/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 03/09/2008 and displayed until 20/11/2008
Reasons for adding or updating:
  • Change to Further Information section
  • Change to dosage and administration
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 27/05/2008 and displayed until 03/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 29/08/2007 and displayed until 27/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change of contra-indications
Updated on 21/06/2007 and displayed until 29/08/2007
Reasons for adding or updating:
  • Change to drug interactions
  • Change of contra-indications
Updated on 12/02/2007 and displayed until 21/06/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 18/01/2007 and displayed until 12/02/2007
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
Updated on 28/01/2005 and displayed until 18/01/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 16/11/2004 and displayed until 28/01/2005
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to warnings or special precautions for use
Updated on 16/11/2004 and displayed until 16/11/2004
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to warnings or special precautions for use
Updated on 19/04/2004 and displayed until 16/11/2004
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
Updated on 10/12/2003 and displayed until 19/04/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  indinavir sulphate